What Does Urolithin A Actually Have to Do With Muscle?

When people think about maintaining muscle as they age, the conversation usually starts with:

Protein. Strength training. Exercise.

All of those matter.

But researchers are also looking much deeper inside the muscle cell itself.

One area attracting attention is the mitochondria, the cellular structures involved in producing much of the energy muscles need to function.

Mitochondria don't remain perfectly functional forever.

Cells therefore have quality-control systems that help identify and recycle damaged or dysfunctional mitochondria.

One of those processes is called mitophagy.

And that's where Urolithin A has become particularly interesting.

Human trials have now investigated Urolithin A in relation to muscle strength, endurance, walking performance, mitochondrial biomarkers and physical function.

But before looking at those results, there's an unusual part of Urolithin A biology worth understanding:

Not everyone naturally produces it in the same way.

What Is Urolithin A?

Urolithin A isn't simply a nutrient found in large quantities inside a particular fruit.

Instead, it's a metabolite produced by certain gut bacteria.

Foods including:

• Pomegranates
• Walnuts
• Strawberries
• Raspberries

contain compounds known as ellagitannins and ellagic acid.

After these compounds reach the digestive system, certain gut microorganisms can transform them into metabolites called urolithins.

One of those metabolites is Urolithin A.

The simplified pathway looks like this:

This means eating a pomegranate isn't necessarily the same thing as directly consuming a defined amount of Urolithin A.

And there's another complication.

Not Everyone's Gut Produces Urolithin A the Same Way

Your gut microbiome helps determine which urolithins you produce.

Researchers have identified different urolithin metabotypes based on how individuals metabolize ellagic acid.

These include people whose microbiota predominantly produce Urolithin A, people who generate additional urolithins, and individuals who do not produce the final urolithins in detectable amounts.

The composition of the gut microbiome therefore creates substantial person-to-person variability in natural Urolithin A production.

Explore the research on Urolithin A and the gut microbiome

That's one reason researchers have investigated direct Urolithin A supplementation.

Instead of depending on gut bacteria to convert dietary precursors into Urolithin A, researchers can administer a defined amount directly and measure what happens.

Why Are Scientists Interested in Mitophagy?

To understand Urolithin A research, we need to go inside the muscle cell.

Muscle cells have high energy demands.

Mitochondria play an important role in meeting those demands by participating in the production of ATP — the molecule cells use as an immediate source of chemical energy.

But mitochondria can become damaged or dysfunctional.

Cells therefore need ways to maintain mitochondrial quality.

One of those processes is:

Mitophagy

Mitophagy is a specialized form of cellular recycling that helps identify and remove damaged or dysfunctional mitochondria.

Think of it as mitochondrial quality control:

Preclinical research has identified Urolithin A as a compound capable of activating pathways associated with mitophagy.

This created an intriguing hypothesis:

Could Urolithin A influence mitochondrial health in human muscle and could that translate into measurable changes in physical function?

Human clinical trials have begun investigating exactly that.

What Do Urolithin A Human Trials Actually Measure?

This is an important question because "mitochondrial health" can sound vague.

Clinical researchers need measurable outcomes.

Urolithin A trials have therefore examined endpoints including:

Muscle strength

How much force a muscle can generate.

Muscle endurance

How long muscles can repeatedly contract before becoming fatigued.

Six-minute walking distance

How far someone can walk within six minutes.

VO₂ peak

A measurement related to aerobic capacity.

ATP production

Researchers can assess mitochondrial energy-production capacity in muscle.

Mitochondrial biomarkers

Blood and muscle measurements can provide additional information about mitochondrial metabolism and pathways associated with mitophagy.

These endpoints allow researchers to test whether changes in cellular biology correspond with changes people can actually measure physically.

What Happened in Older Adults?

A randomized clinical trial published in JAMA Network Open investigated Urolithin A in 66 adults aged 65 to 90 years.

Participants received either:

1,000 mg Urolithin A per day

or

Placebo

for four months.

Researchers evaluated several outcomes, including six-minute walking distance, maximal ATP production, muscle endurance and biomarkers associated with mitochondrial health.

So what happened?

The Primary Outcomes Tell an Important Story

Researchers reported an improvement in six-minute walking distance within the Urolithin A group.

But compared with placebo, the difference was not statistically significant.

Similarly, researchers did not find a significant treatment effect on maximal ATP production in the measured hand or leg muscles.

That's important because these were key outcomes.

So it would be inaccurate to summarize the trial as:

"Urolithin A significantly improved everything related to mitochondrial function."

It didn't.

But the researchers found other signals.

What Happened to Muscle Endurance?

Researchers measured how long participants could repeatedly contract muscles in the hand and leg before fatigue.

At two months, Urolithin A supplementation significantly improved muscle endurance in both measured muscles compared with placebo.

At four months, endurance continued to improve in the Urolithin A group, but improvement in the placebo group meant that the between-group treatment effect was no longer significant.

This is a good example of why reading beyond the headline matters.

The findings were interesting.

But they weren't uniform across every endpoint or every time point.

Researchers Also Measured Mitochondrial Biomarkers

The study didn't stop at physical performance.

Researchers analyzed blood biomarkers associated with mitochondrial metabolism.

Urolithin A supplementation was associated with reductions in several acylcarnitines, molecules researchers can examine when investigating mitochondrial fatty-acid metabolism.

Changes were also reported in several ceramide species.

The researchers interpreted the overall biomarker pattern as supportive evidence of changes in mitochondrial health.

But biomarkers and physical outcomes aren't interchangeable.

A change in a mitochondrial biomarker does not automatically mean someone has become stronger, younger or more physically capable.

That's why clinical trials measure both.

What About Middle-Aged Adults?

Another randomized, placebo-controlled trial investigated Urolithin A supplementation for four months in middle-aged adults.

Researchers tested two doses and examined outcomes involving:

• Muscle strength
• Peak power
• VO₂ peak
• Six-minute walking performance
• Blood biomarkers
• Muscle proteins associated with mitochondrial metabolism and mitophagy

The researchers reported improvements in muscle strength and changes in biomarkers and muscle proteins associated with mitochondrial health.

However, the study did not find a significant improvement in its primary endpoint of peak power output.

Read the middle-aged adult Urolithin A trial on PubMed

Again, the pattern is more nuanced than a simple "works" or "doesn't work."

Different measurements produced different results.

What Has Human Research Established?

Based on the clinical evidence so far, researchers have established several useful points.

Urolithin A can be administered directly to humans, bypassing differences in gut microbial conversion from ellagitannin-rich foods.

Human trials have reported signals involving muscle endurance, muscle strength and biomarkers associated with mitochondrial metabolism under specific study conditions.

Researchers have also detected changes in proteins and molecular pathways associated with mitochondrial metabolism and mitophagy in human muscle in clinical research.

But that doesn't mean every proposed benefit has been established.

What Is Still Under Investigation?

Human trials have not established that Urolithin A:

• Reverses muscle aging
• Prevents age-related muscle loss
• Rebuilds damaged mitochondria in every person
• Improves every measure of physical performance
• Extends human lifespan
• Replaces exercise
• Produces identical results across all formulations and doses

And some important primary outcomes in clinical trials have not significantly improved compared with placebo.

That's not a reason to dismiss the research.

It's a reason to interpret it correctly.

The evidence suggests that Urolithin A interacts with biological pathways worth investigating, while larger and longer studies are needed to understand its clinical significance.

Exercise Still Matters

There's another important point.

Research into Urolithin A doesn't change what we already know about maintaining muscle.

Resistance training, regular physical activity, adequate nutrition and sufficient protein remain central to supporting muscle health.

Urolithin A research asks whether mitochondrial quality-control pathways can provide an additional target within that bigger picture.

It's not:

Exercise OR Urolithin A.

It's a question of whether compounds affecting mitochondrial biology could eventually complement established healthy-aging strategies.

A Note About the Clinical Research

Transparency matters here.

Several influential Urolithin A human trials used a specific proprietary Urolithin A formulation and had involvement or funding from the company associated with that formulation.

For example, the older-adult JAMA Network Open trial was supported by Amazentis SA, and the publication disclosed company affiliations and intellectual-property interests. The funder also had a role in study design, data activities, manuscript preparation/review and the decision to submit the research.

Industry involvement does not automatically invalidate a study.

But it is relevant context when interpreting the evidence.

It also reinforces an important point:

Results obtained with a specific researched formulation should not automatically be attributed to every Urolithin A supplement on the market.

So Why Is Urolithin A Interesting for Healthy Aging?

Because it connects several areas scientists are actively studying:

That's a compelling biological pathway.

And unlike many compounds discussed in longevity circles only because of cell or animal experiments, Urolithin A has progressed into randomized human clinical trials measuring physical and molecular outcomes.

The results aren't definitive.

But they're substantial enough to make Urolithin A an interesting area of ongoing muscle and mitochondrial research.

Explore Aeternum Urolithin A

If you're interested in Urolithin A after exploring the research, the next step is to look carefully at the actual product you're considering.

Review the:

Urolithin A amount → serving information → complete formulation → quality information → testing information

and distinguish those product specifications from findings obtained with formulations used in published clinical trials.

Explore Aeternum Urolithin A product information →

Have questions about the formulation or how it differs from Urolithin A used in published research?

Message Aeternum for product information before deciding whether it's right for your routine.

The Bottom Line

Urolithin A begins with an unusual biological story.

Certain gut bacteria can transform compounds found in foods such as pomegranates and walnuts into urolithins but people differ in their ability to produce them.

That led researchers to study direct Urolithin A supplementation.

The biological rationale centers heavily on mitochondrial quality control and mitophagy, while human trials have gone further by measuring muscle strength, endurance, walking performance, ATP production and mitochondrial biomarkers.

Some outcomes have improved.

Others haven't significantly differed from placebo.

So the strongest conclusion isn't that Urolithin A has been proven to reverse muscle aging.

It's that:

Urolithin A has moved from an interesting gut-derived metabolite into human clinical research and scientists are now testing whether its effects on mitochondrial biology translate into meaningful changes in muscle function and healthy aging.

That's the research worth following.

Research Featured in This Article

Liu S, D'Amico D, Shankland E, et al. (2022).
Effect of Urolithin A Supplementation on Muscle Endurance and Mitochondrial Health in Older Adults: A Randomized Clinical Trial.
JAMA Network Open. PMID: 35050355.

Read the older-adult clinical trial on PubMed

Singh A, D'Amico D, Andreux PA, et al. (2022).
Urolithin A improves muscle strength, exercise performance, and biomarkers of mitochondrial health in a randomized trial in middle-aged adults.
Cell Reports Medicine. PMID: 35584623.

Read the middle-aged adult clinical trial on PubMed

García-Villalba R, et al. (2022).
Urolithins: a Comprehensive Update on their Metabolism, Bioactivity, and Associated Gut Microbiota.
PMID: 35118817.